Very low levels of remdesivir resistance in SARS-COV-2 genomes after 18 months of massive usage during the COVID19 pandemic: A GISAID exploratory analysis
出版年份 2022 全文链接
标题
Very low levels of remdesivir resistance in SARS-COV-2 genomes after 18 months of massive usage during the COVID19 pandemic: A GISAID exploratory analysis
作者
关键词
SARS-CoV-2, COVID-19, Remdesivir, Resistance, RNA-Dependent RNA polymerase, Nsp12, E802D, Molnupiravir
出版物
ANTIVIRAL RESEARCH
Volume 198, Issue -, Pages 105247
出版商
Elsevier BV
发表日期
2022-01-13
DOI
10.1016/j.antiviral.2022.105247
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Genetic conservation of SARS-CoV-2 RNA replication complex in globally circulating isolates and recently emerged variants from humans and minks suggests minimal pre-existing resistance to remdesivir
- (2021) Ross Martin et al. ANTIVIRAL RESEARCH
- Emergence of varicella-zoster virus resistance to acyclovir: epidemiology, prevention, and treatment
- (2021) Kimiyasu Shiraki et al. Expert Review of Anti-Infective Therapy
- β-D-N 4-hydroxycytidine (NHC) Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian Cells
- (2021) Shuntai Zhou et al. JOURNAL OF INFECTIOUS DISEASES
- Global Genomic Analysis of SARS-CoV-2 RNA Dependent RNA Polymerase Evolution and Antiviral Drug Resistance
- (2021) Alfredo Mari et al. Microorganisms
- Structure-Based Virtual Screening to Identify Novel Potential Compound as an Alternative to Remdesivir to Overcome the RdRp Protein Mutations in SARS-CoV-2
- (2021) Thirumal Kumar D et al. Frontiers in Molecular Biosciences
- Evolution of viral variants in remdesivir‐treated and untreated SARS‐CoV‐2‐infected pediatrics patients
- (2021) Florencia A. T. Boshier et al. JOURNAL OF MEDICAL VIROLOGY
- Machine learning identifies molecular regulators and therapeutics for targeting SARS‐CoV2‐induced cytokine release
- (2021) Marina Chan et al. Molecular Systems Biology
- Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis
- (2021) Florian Kabinger et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Molnupiravir: coding for catastrophe
- (2021) Brandon Malone et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- In vitro selection of Remdesivir resistance suggests evolutionary predictability of SARS-CoV-2
- (2021) Agnieszka M. Szemiel et al. PLoS Pathogens
- A Possible Role of Remdesivir and Plasma Therapy in the Selective Sweep and Emergence of New SARS-CoV-2 Variants
- (2021) Philippe Colson et al. Journal of Clinical Medicine
- Prediction of remdesivir resistance in COVID-19 illness: Need for development of clinical laboratory test
- (2021) Deepak Kumar et al. Indian Journal of Clinical Biochemistry
- Oral prodrug of remdesivir parent GS-441524 is efficacious against SARS-CoV-2 in ferrets
- (2021) Robert M. Cox et al. Nature Communications
- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
- (2020) Manli Wang et al. CELL RESEARCH
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structural basis for RNA replication by the SARS-CoV-2 polymerase
- (2020) Quan Wang et al. CELL
- Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
- (2020) Chenguang Shen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant
- (2020) Maria Pachetti et al. Journal of Translational Medicine
- Structure of the RNA-dependent RNA polymerase from COVID-19 virus
- (2020) Yan Gao et al. SCIENCE
- An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice
- (2020) Timothy P. Sheahan et al. Science Translational Medicine
- A Structural View of SARS-CoV-2 RNA Replication Machinery: RNA Synthesis, Proofreading and Final Capping
- (2020) Maria Romano et al. Cells
- SARS‐CoV‐2 and SARS‐CoV: Virtual screening of potential inhibitors targeting RNA‐dependent RNA polymerase activity (NSP12)
- (2020) Zijing Ruan et al. JOURNAL OF MEDICAL VIROLOGY
- Tissue distributions of antiviral drugs affect their capabilities of reducing viral loads in COVID-19 treatment
- (2020) Yan Wang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Analysis of the Potential for N4-Hydroxycytidine to Inhibit Mitochondrial Replication and Function
- (2019) Zachary M. Sticher et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Orally Efficacious Broad-Spectrum Ribonucleoside Analog Inhibitor of Influenza and Respiratory Syncytial Viruses
- (2018) Jeong-Joong Yoon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
- (2018) Maria L. Agostini et al. mBio
- Galidesivir, a Direct-Acting Antiviral Drug, Abrogates Viremia in Rhesus Macaques Challenged with Zika Virus
- (2017) So-Yon Lim et al. Open Forum Infectious Diseases
- Structure Guided Design of Potent and Selective Ponatinib-Based Hybrid Inhibitors for RIPK1
- (2015) Malek Najjar et al. Cell Reports
- Favipiravir (T-705), a novel viral RNA polymerase inhibitor
- (2013) Yousuke Furuta et al. ANTIVIRAL RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now